Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion type Assertion NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_head.
- NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion description "[The secondary ?-dystroglycanopathies usually present in infancy as congenital muscular dystrophies but may manifest later in childhood or adult life (limb-girdle muscular dystrophy (LGMD) 2I, LGMD2K, LGMD2M, LGMD2N, and LGMD2O).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_provenance.
- NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion evidence source_evidence_literature NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_provenance.
- NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion SIO_000772 21496628 NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_provenance.
- NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion wasDerivedFrom befree-20140225 NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_provenance.
- NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_assertion wasGeneratedBy ECO_0000203 NP914938.RAA8VFahOHqbrQZNHrNJdttC-5g13fMeyKHYpC01-FSNo130_provenance.